Cycloalkyl substituted pyrimidinediamine compounds and their uses

US7868013B2 · kind B2 · utility

Assignee

• Rigel Pharmaceuticals, Inc. · US

Inventors

• Hui Li · Santa Clara, US
• Ankush Argade · Foster City, US
• Rajinder Singh · Belmont, US
• Sambaiah Thota · Fremont, US
• David Carroll · San Francisco, US
• Kin Tso · San Francisco, US
• Vanessa Taylor · San Francisco, US
• John McLaughlin · Media, US
• Mark Markovtsov · Foster City, US

Key dates

• Filing date: Dec 6, 2006
• Grant date: Jan 11, 2011
• Expiry date: May 31, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.